- Home
- NSPR vs BYSI Comparison
NSPR vs BYSI Comparison
Compare NSPR & BYSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSPR
- BYSI
- Stock Information
- Founded
- NSPR 2005
- BYSI 2010
- Country
- NSPR United States
- BYSI United States
- Employees
- NSPR N/A
- BYSI N/A
- Industry
- NSPR Medical/Dental Instruments
- BYSI Biotechnology: Pharmaceutical Preparations
- Sector
- NSPR Health Care
- BYSI Health Care
- Exchange
- NSPR Nasdaq
- BYSI Nasdaq
- Market Cap
- NSPR 79.7M
- BYSI 72.1M
- IPO Year
- NSPR N/A
- BYSI 2017
- Fundamental
- Price
- NSPR $2.60
- BYSI $1.78
- Analyst Decision
- NSPR Strong Buy
- BYSI
- Analyst Count
- NSPR 2
- BYSI 0
- Target Price
- NSPR $4.75
- BYSI N/A
- AVG Volume (30 Days)
- NSPR 48.2K
- BYSI 32.8K
- Earning Date
- NSPR 05-09-2025
- BYSI 01-01-0001
- Dividend Yield
- NSPR N/A
- BYSI N/A
- EPS Growth
- NSPR N/A
- BYSI N/A
- EPS
- NSPR N/A
- BYSI N/A
- Revenue
- NSPR $7,009,000.00
- BYSI N/A
- Revenue This Year
- NSPR $28.93
- BYSI N/A
- Revenue Next Year
- NSPR $172.18
- BYSI N/A
- P/E Ratio
- NSPR N/A
- BYSI N/A
- Revenue Growth
- NSPR 12.96
- BYSI N/A
- 52 Week Low
- NSPR $2.07
- BYSI $0.98
- 52 Week High
- NSPR $3.80
- BYSI $3.63
- Technical
- Relative Strength Index (RSI)
- NSPR 49.84
- BYSI 56.52
- Support Level
- NSPR $2.40
- BYSI $1.64
- Resistance Level
- NSPR $2.79
- BYSI $2.14
- Average True Range (ATR)
- NSPR 0.16
- BYSI 0.17
- MACD
- NSPR 0.01
- BYSI 0.04
- Stochastic Oscillator
- NSPR 60.42
- BYSI 56.63
About NSPR InspireMD Inc.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.
About BYSI BeyondSpring Inc.
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It has two reportable segments Plinabulin pipeline and the TPD platform.